Berkeley, CA, United States of America

Michael J Cope

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Renibus Therapeutics, Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Michael J Cope. Retrieved from https://idiyas.com/inventor/michael-j-cope-yhuxutke

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 10.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Michael J Cope: Innovator in Pharmaceutical Compositions

Introduction

Michael J Cope is a notable inventor based in Berkeley, CA (US). He has made significant contributions to the field of pharmaceutical compositions, particularly in treating acid-base disorders. His innovative work has the potential to impact the medical community positively.

Latest Patents

Michael J Cope holds a patent for "HCL-binding compositions for and methods of treating acid-base disorders." This patent describes pharmaceutical compositions designed to treat animals, including humans. The compositions contain nonabsorbable components that can help normalize serum bicarbonate concentrations and blood pH levels in patients suffering from various metabolic conditions.

Career Highlights

Cope's career is marked by his dedication to advancing medical treatments through innovative pharmaceutical solutions. His work at Renibus Therapeutics, Inc. showcases his commitment to developing effective therapies for acid-base disorders.

Collaborations

Some of his notable coworkers include Randi K Gbur and Scott M Tabakman. Their collaboration contributes to the innovative environment at Renibus Therapeutics, Inc.

Conclusion

Michael J Cope's contributions to pharmaceutical compositions highlight his role as an innovator in the medical field. His patent for HCL-binding compositions represents a significant advancement in treating acid-base disorders.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…